A critical role for lymphotoxin-β receptor in the development of diabetes in nonobese diabetic mice

被引:50
|
作者
Ettinger, R
Munson, SH
Chao, CC
Vadeboncoeur, M
Toma, J
McDevitt, HO [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[3] Hyseq, Sunnyvale, CA 94085 USA
[4] Basel Inst Immunol, CH-4005 Basel, Switzerland
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2001年 / 193卷 / 11期
关键词
autoimmune disease; tumor necrosis factor; LIGHT; lymphoid development; marginal zone;
D O I
10.1084/jem.193.11.1333
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To assess the role of lymphotoxin-beta receptor (LT betaR) in diabetes pathogenesis, we expressed an LT betaR-Fc fusion protein in nonobese diabetic (NOD) mice. The fusion protein was expressed in the embryo, reached high levels for the first 2 wk after birth, and then declined progressively with age. High expression of LT betaR-Fc blocked diabetes development but not insulitis. After the decline in chimeric protein concentration, mice became diabetic with kinetics similar to the controls. Early expression of fusion protein resulted in disrupted splenic architecture. However, primary follicles and follicular dendritic cells, but not marginal zones, developed in aged mice. Hence, LT betaR signaling is required for diabetes development and regulates follicular and marginal zone structures via qualitatively or quantitatively distinct mechanisms.
引用
收藏
页码:1333 / 1339
页数:7
相关论文
共 50 条
  • [41] EFFECT OF CYCLOSPORINE ON IMMUNOLOGICALLY MEDIATED DIABETES IN NONOBESE DIABETIC MICE
    WANG, Y
    MCDUFFIE, M
    NOMIKOS, IN
    HAO, LM
    LAFFERTY, KJ
    TRANSPLANTATION, 1988, 46 (02) : S101 - S106
  • [42] Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice
    Oikawa, Y
    Shimada, A
    Kasuga, A
    Morimoto, J
    Osaki, T
    Tahara, H
    Miyazaki, T
    Tashiro, F
    Yamato, E
    Miyazaki, J
    Saruta, T
    JOURNAL OF IMMUNOLOGY, 2003, 171 (11): : 5865 - 5875
  • [43] A role for HVEM, but not lymphotoxin-β receptor, in LIGHT-induced tumor cell death and chemokine production
    Pasero, Christine
    Barbarat, Bernadette
    Just-Landi, Sylvaine
    Bernard, Alain
    Aurran-Schleinitz, Therese
    Rey, Jerome
    Eldering, Eric
    Truneh, Alemsedeg
    Costello, Regis T.
    Olive, Daniel
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (09) : 2502 - 2514
  • [44] Toll-Like Receptor 7 Is Required for Lacrimal Gland Autoimmunity and Type 1 Diabetes Development in Male Nonobese Diabetic Mice
    Debreceni, Ivy L.
    Chimenti, Michael S.
    Serreze, David, V
    Geurts, Aron M.
    Chen, Yi-Guang
    Lieberman, Scott M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 19
  • [45] Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice
    Greeley, SAW
    Katsumata, M
    Yu, LP
    Eisenbarth, GS
    Moore, DJ
    Goodarzi, H
    Barker, CF
    Naji, A
    Noorchashm, H
    NATURE MEDICINE, 2002, 8 (04) : 399 - 402
  • [46] Fas is detectable on β cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice
    Darwiche, R
    Chong, MMW
    Santamaria, P
    Thomas, HE
    Kay, TWH
    JOURNAL OF IMMUNOLOGY, 2003, 170 (12): : 6292 - 6297
  • [47] PREVENTION OF DIABETES IN NONOBESE DIABETIC I-AK TRANSGENIC MICE
    SLATTERY, RM
    KJERNIELSEN, L
    ALLISON, J
    CHARLTON, B
    MANDEL, TE
    MILLER, JFAP
    NATURE, 1990, 345 (6277) : 724 - 726
  • [48] I-E+ NONOBESE DIABETIC MICE DEVELOP INSULITIS AND DIABETES
    PODOLIN, PL
    PRESSEY, A
    DELARATO, NH
    FISCHER, PA
    PETERSON, LB
    WICKER, LS
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03): : 793 - 803
  • [49] Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice
    Maki, T
    Gottschalk, R
    Monaco, AP
    TRANSPLANTATION, 2002, 74 (12) : 1684 - 1686
  • [50] Chimerism-induced remission of overt diabetes in nonobese diabetic mice
    Li, H
    Inverardi, L
    Ricordi, C
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 640 - 640